Price (delayed)
$6.85
Market cap
$1.58B
P/E Ratio
8.56
Dividend/share
N/A
EPS
$0.8
Enterprise value
$8.56B
Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system. While Endo's management, operations,
There are no recent dividends present for ENDP.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.